$HSIC (Henry Schein, Inc.)

$HSIC {{ '2016-05-25T17:59:01+0000' | timeago}} • SEC

$HSIC said the total amount of unrecognized tax benefits as of March 26, 2016 was approx. $101.4MM, of which $80.6MM would affect the effective tax rate if recognized. The company expects the amount of unrecognized tax benefits to change in the next 12 months. However, $HSIC does not expect the change to be material to finances.

$HSIC {{ '2017-09-18T13:34:28+0000' | timeago}} • Announcement

The BoD of $HSIC has authorized repurchase of up to $400MM of shares of the company's common stock. This is further to the $400MM repurchase program announced in Oct 2016. The firm had approx 158MM shares outstanding as on Sept 15, 2017 and the new authorization represents approx 3% of shares outstanding at current stock price.

$HSIC {{ '2017-08-28T20:15:13+0000' | timeago}} • Announcement

$HSIC agreed to buy Merritt Veterinary Supplies, Inc., an independent, family-owned supplier of animal health products, for undisclosed terms. $HSIC expects the acquisition to be neutral to its 2017 EPS and to be accretive thereafter. Upon the closing, which is expected in 3Q17, Merritt will become part of Henry Schein Animal Health.

$HSIC {{ '2017-08-16T16:54:10+0000' | timeago}} • Announcement

$HSIC's division Henry Schein Dental entered into an agreement with CAEK, Inc., a Software-as-a-Service company, to purchase CAEK’s HIPAA software, LayerCompliance. LayerCompliance helps healthcare practitioners navigate the requirements of the Health Insurance Portability and Accountability Act.

$HSIC {{ '2017-08-16T12:48:15+0000' | timeago}} • Announcement

The BoD of $HSIC has given nod for a 2-for-1 split of the company's common stock. Each Henry Schein stockholder of record as on Sept 1, 2017, will receive a dividend of one additional share for every share held, and trading will begin on a split-adjusted basis on Sept 15, 2017. Following the split, $HSIC will have approx. 158MM shares outstanding.

$HSIC {{ '2017-06-28T12:03:39+0000' | timeago}} • Announcement

$HSIC extended its existing agreement in Canada with $XRAY to include the CEREC CAD/CAM restoration system and the Schick line of imaging sensors. Henry Schein Canada will represent the entire $XRAY product line, effective Sept. 1, 2017. The revised agreement is expected to be neutral to $HSIC EPS in 2017 and accretive thereafter.

$HSIC {{ '2017-06-27T20:45:25+0000' | timeago}} • Announcement

$HSIC settled litigation with SourceOne Dental Inc. that will result in a $0.04 per share charge when the company reports its 2Q17 results. The company denies any wrongdoing related to the SourceOne litigation and chose to pursue a settlement solely to avoid further distraction and cost resulting from this matter.

$HSIC {{ '2017-05-09T15:05:15+0000' | timeago}} • Webcast

$HSIC believes the market for implants is growing strongly throughout the world. Implants grew mid-single digits worldwide with good growth in the US. Europe is a bit muted while the developing world is growing significantly. The investments by specialists in digital technology is driving equipment sales throughout the world.

$HSIC {{ '2017-05-09T14:52:21+0000' | timeago}} • Webcast

$HSIC does not see much change in its go-to-market strategy. The company has been building its digital technology and capacity for the last 4-5 years. The goal is to provide the best comprehensive solution to dentists. $HSIC has invested heavily in its practice solutions software. $HSIC will continue to add more resources and expand its offerings.

$HSIC {{ '2017-05-09T12:18:37+0000' | timeago}} • Announcement

$HSIC afffirmed its 2017 EPS guidance of $7.17-7.30. This guidance reflects growth of 16-18% compared with 2016 EPS of $6.19, and growth of 8-10% compared with 2016 non-GAAP EPS of $6.61. The company noted that FY17 includes one less week than FY16.

$HSIC {{ '2017-05-09T12:16:27+0000' | timeago}} • Announcement

$HSIC reported a rise in 1Q17 earnings driven by higher sales. Net income rose to $140.75MM or $1.76 per share from $113.75MM or $1.37 per share last year. Net sales grew to $2.92Bil from $2.71Bil, on 8.7% growth in local currencies and a 1.0% decline related to foreign currency exchange.

$XRAY {{ '2017-05-09T11:11:53+0000' | timeago}} • Announcement

$XRAY announced a new distribution agreement with $PDCO, continuing its partnership over many years. Additionally, $XRAY announced a new three-year agreement with $HSIC, effective September 1, 2017 to distribute $XRAY's full line of dental equipment in the US.

$HSIC {{ '2017-05-02T14:40:25+0000' | timeago}} • Announcement

$HSIC, a provider of health care products and services, has completed its acquisition of Southern Anesthesia Surgical, a distributor of anesthesia and surgical supplies. The transaction was announced on February 20, 2017. Financial terms of the transaction were not disclosed.

$HSIC {{ '2017-05-02T14:21:43+0000' | timeago}} • Announcement

$HSIC completed acquisition of Southern Anesthesia Surgical (SAS), a U.S. distributor of anesthesia and surgical supplies to oral surgeons, dental anesthesiologists, and periodontists. The SAS business will continue to be led by its current management team, including Bill Alexander, VP and General Manager.

$HSIC {{ '2017-04-19T12:44:45+0000' | timeago}} • Announcement

$HSIC amended its revolving credit facility, including an increase in the maximum borrowing amount from $500MM to $750MM, and an extension of the facility through September 2022. JP Morgan Securities LLC and U.S. Bank NA served as Joint Lead Arrangers for the new facility.

$HSIC {{ '2017-02-22T15:04:47+0000' | timeago}} • Announcement

Henry Schein Medical, an $HSIC company, signed an exclusive distribution agreement with Rijuven, which develops innovative digital medical devices, to sell its CardioSleeve diagnostic device to medical practitioners.

$HSIC {{ '2017-02-21T19:18:26+0000' | timeago}} • Webcast

The global animal health market is healthy and growing, particularly in the companion animal segment, where $HSIC has expanded opportunities to deliver value-added solutions. The company continued to gain market share in 4Q16. $HSIC is well-positioned to leverage attractive opportunities in the animal health markets.

$HSIC {{ '2017-02-21T19:04:59+0000' | timeago}} • Webcast

During 4Q16, $HSIC repurchased approx. 1.3MM shares at an average price of $156.10 per share or approx. $200MM. For full-year 2016, the company repurchased $550MM of its stock representing 3.5MM shares at an average price of $158.88 per share. Capex for 2016 was $70.2MM.

$HSIC {{ '2017-02-21T18:56:03+0000' | timeago}} • Webcast

In $HSIC’s Dental segment, North American internal growth in local currency was 2.2% in 4Q16 and included 1.9% growth in sales of dental consumable merchandise and 2.7% growth in dental equipment sales and services revenue.

$HSIC {{ '2017-02-21T15:35:29+0000' | timeago}} • Announcement

$HSIC agreed to buy Southern Anesthesia Surgical (SAS), a leading U.S. distributor of anesthesia and surgical supplies to oral surgeons, dental anesthesiologists, and periodontists, for undisclosed terms. The agreement is expected to close in 2Q17. SAS will become part of ACE Surgical Supply Co., Inc. (ACE), a subsidiary of $HSIC.

$HSIC {{ '2017-02-21T12:26:51+0000' | timeago}} • Announcement

$HSIC affirms FY17 guidance. The company expects its diluted EPS to be in the range of $7.17-7.30, representing 16-18% growth from FY16.

Recent Transcripts

ONVO (Organovo Holdings, Inc.)
Wednesday, August 9 2017 - 9:00pm
XRAY (DENTSPLY International Inc.)
Wednesday, August 9 2017 - 12:30pm
STE (Steris Plc)
Tuesday, August 8 2017 - 2:00pm
HSIC (Henry Schein, Inc.)
Tuesday, August 8 2017 - 2:00pm
WCG (WellCare Health Plans, Inc.)
Friday, August 4 2017 - 1:00pm
CI (Cigna Corp.)
Friday, August 4 2017 - 12:00pm
TXMD (TherapeuticsMD, Inc.)
Thursday, August 3 2017 - 8:30pm
ARW (Arrow Electronics, Inc.)
Thursday, August 3 2017 - 5:00pm
SYN (Synthetic Biologics Inc.)
Thursday, August 3 2017 - 12:30pm
AGN (Allergan plc)
Thursday, August 3 2017 - 12:30pm
MOH (Molina Healthcare, Inc.)
Wednesday, August 2 2017 - 9:00pm
PLUS (ePlus inc.)
Wednesday, August 2 2017 - 8:30pm
TRXC (TransEnterix, Inc.)
Wednesday, August 2 2017 - 8:30pm
HOLX (Hologic Inc.)
Wednesday, August 2 2017 - 8:30pm
HUM (Humana Inc.)
Wednesday, August 2 2017 - 1:00pm
OMI (Owens & Minor Inc.)
Wednesday, August 2 2017 - 12:00pm
IDXX (IDEXX Laboratories, Inc.)
Tuesday, August 1 2017 - 12:30pm
HSKA (Heska Corporation)
Monday, July 31 2017 - 3:00pm
MD (MEDNAX, Inc.)
Friday, July 28 2017 - 2:00pm
LH (Laboratory Corp. of America Holdings)
Wednesday, July 26 2017 - 1:00pm

AlphaGraphics you may like